Securities and Exchange Commission
Washington, D. C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 29, 2000
IMMUCOR, INC.
(Exact name of registrant as specified in its charter)
Georgia 0-14820 22-2408354
(State or other jurisdiction of (Commission File (I.R.S. Employer
incorporation or organization) Number) Identification No.)
3130 Gateway Drive P.O. Box 5625 Norcross, Georgia 30091-5625
(Address of principal executive offices) (Zip Code)
Registrant's telephone number: (770) 441-2051
<PAGE>
Item 9. Regulation FD Disclosure
At its annual meeting of shareholders held on November 30, 2000, Immucor, Inc.
(the "Company") elected the following 8 persons as directors to serve until the
next annual meeting of shareholders: Edward L. Gallup, Didier L. Lanson, Dennis
M. Smith, Jr., M.D., Ralph A. Eatz, G. Bruce Papesh, Joseph E. Rosen, Dr.
Gioacchino De Chirico, and Daniel T. McKeithan. In addition, the shareholders
approved an amendment to the Company's Articles of Incorporation to increase the
number of authorized shares of common stock of the Company from 30 million
shares to 45 million shares.
At the annual meeting, management of the Company stated that it would implement
significant price increases with respect to its smallest accounts effective
January 1, 2001, and that it would seek to implement significant price increases
with other customers during the fiscal year.
On November 29, 2000, the Board of Directors approved an amendment to the
Company's bylaws increasing from 25% to 50% the number of shares required to
call a special meeting of the shareholders. At the same meeting, the Board of
Directors approved an amendment to the Company's Rights Agreement dated as of
April 16, 1999 with EquiServe Trust Company, N.A., to lower the level of stock
ownership necessary to trigger such Rights from 20% to 15%.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IMMUCOR, INC.
Date: November 30, 2000 By: /s/ Edward L.Gallup
Edward L. Gallup,
Chief Executive Officer
/s/ Steven C. Ramsey
Steven C. Ramsey,
Chief Financial Officer
